Altogether, these results demonstrate that cytoplasmic pEZH2(T367) is expressed in invasive and metastatic breast carcinomas where it is associated with higher histological grade, a measure of tumor aggressiveness, ER- status, and breast cancer progression. Here, ESR1 is linked to breast cancer.